Thus, recent studies in the orthotopic Hepa1-6 HCC mouse model identify the CCL2/CCR2 axis as critical for HSPC recruitment to the spleen of tumor bearing mice, and establish its effective suppression by CCR2 antagonists (50). This evidence concerns the gene CCR2 and hepatocellular carcinoma.